BlueSpruce Investments’s Thermo Fisher Scientific TMO Stock Holding History

BlueSpruce Investments’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-398,018	Closed	-$231M	–	11
2025 Q4	$231M	Sell	398,018 -166,475	-29%	-$94.1M	5.89%	8
2025 Q3	$274M	Sell	564,493 -101,257	-15%	-$47.1M	6.29%	8
2025 Q2	$270M	Buy	665,750 +102,704	+18%	+$42.9M	6.28%	9
2025 Q1	$280M	Sell	563,046 -250,775	-31%	-$136M	6.54%	10
2024 Q4	$423M	Buy	813,821 +178,190	+28%	+$98M	8.6%	5
2024 Q3	$393M	Sell	635,631 -138,969	-18%	-$82.3M	7.25%	7
2024 Q2	$428M	Sell	774,600 -68,645	-8%	-$39.3M	7.87%	7
2024 Q1	$490M	Sell	843,245 -232,332	-22%	-$130M	8.76%	7
2023 Q4	$571M	Buy	1,075,577 +317,952	+42%	+$154M	10.9%	4
2023 Q3	$383M	Buy	+757,625	New	+$404M	6.99%	8

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlueSpruce Investments's TMO Position: Q1 2026 in Review

BlueSpruce Investments sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 398,018 shares — an estimated $231M sold.

BlueSpruce Investments first reported a position in TMO in Q3 2023 and held it in 10 quarters. The position peaked at $571M in Q4 2023. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

BlueSpruce Investments reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
BlueSpruce Investments sold 398,018 Thermo Fisher Scientific shares in Q1 2026, an estimated $231M.
BlueSpruce Investments first reported a position in Thermo Fisher Scientific in Q3 2023 and held it in 10 quarters.
BlueSpruce Investments's Thermo Fisher Scientific position peaked at $571M in Q4 2023.
2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on BlueSpruce Investments's 13F filing for Q1 2026, filed 15 May 2026.